到 2030 年曲馬多藥品市場預測：按類型、劑型、配銷通路和地區分類的全球分析

根據 Stratistics MRC 的數據，2023 年全球曲馬多藥品市場規模為 49 億美元，預計 2030 年將達到 88.4 億美元，預測期內複合年成長率為 8.8%。

用於治療疼痛的人造鴉片類止痛藥稱為曲馬多。通常建議用於治療中度至重度疼痛。與傳統鴉片類藥物相比，曲馬多透過與 mu-鴉片類受體結合並抑制血清素和去甲腎上腺素的再攝取發揮作用。此外，與其他鴉片類藥物相比，這種雙重作用可以降低呼吸抑制的風險，同時也有助於藥物的鎮痛作用。

根據美國疾病管制與預防中心 (CDC) 的數據，美國約有 5,850 萬名成年人被醫生診斷出患有關節炎，預計到 2040 年將有 7,840 萬人被診斷出患有關節炎。

增加有關疼痛管理的知識

公眾和醫療保健專業人員對疼痛管理的認知日益增強，因此越來越關注安全有效的疼痛緩解方法。曲馬多在疼痛治療方面有著悠久的成功歷史，並從這一發展中受益。此外，對客製化治療方法的持續需求以及對各種疼痛管理替代方案的認知不斷提高是推動製藥業曲馬多銷售的因素。

耐受性和副作用的發展

曲馬多廣泛普及的障礙之一是噁心、頭暈、便秘等副作用的發生。此外，重複使用可能會導致耐受性，並且需要改變劑量以保持有效性。醫療負責人必須仔細權衡鎮痛的需要與控制副作用和耐受性。這項決定將影響曲馬多的普遍可接受性和長期使用。

創新的配方方法

曲馬多藥物的持續開發存在機會。透過專注於尖端給藥方法（例如聯合治療和緩釋性）的研究和開發舉措，可以提高藥物療效和患者依從性。此外，解決給藥頻率、副作用和整體治療結果等問題的改進配方可能會使曲馬多成為更複雜、更適應性的疼痛管理解決方案。

競爭替代疼痛管理療法

疼痛管理市場不斷變化，不斷研究的結果正在開發新的治療方法。曲馬多的市場佔有率面臨來自非鴉片類鎮痛藥、醫療設備和非藥物干預措施的競爭的風險。此外，曲馬多在功效、安全性和患者偏好方面面臨著醫療保健提供者考慮的其他疼痛治療方案的競爭。

COVID-19 的影響

曲馬多藥品市場受到了 COVID-19大流行的各種影響。由於對醫療保健和藥物的日益關注，對疼痛管理解決方案的需求不斷增加，但由於全球供應鏈的中斷、醫療保健優先事項的轉變以及資源重新分配到與流行病相關的動態上，市場動態正在發生變化，也受到影響。此外，醫療服務的關閉和限制也影響了患者獲得護理的機會，也可能影響一般曲馬多的消費量和處方實踐。

錠劑市場預計將在預測期內成為最大的市場

在曲馬多藥品市場中，錠劑預計將佔據最大佔有率。錠劑因其穩定性、攜帶性和易用性而受到青睞。錠劑因其保存期限長、給藥準確且對患者友好而受到強烈推薦。在許多治療層級中，錠劑是一種方便且首選的型態，可以提高患者的用藥醫囑遵從性。此外，由於其一致的製造流程、堅固耐用和攜帶的特性以及深受患者和醫療保健專業人員的歡迎，錠劑在製藥行業獲得了最大的市場佔有率。

預計線上藥房領域在預測期內將出現最高的複合年成長率

在曲馬多藥品市場中，線上藥局市場成長最快。線上藥局的快速擴張是由於數位平台的使用增加、電子商務的進步以及它們為客戶提供的易用性。此外，人們可以在舒適的家中線上訂購和獲取藥物，從而省去了前往實體藥房的麻煩。

佔比最大的地區：

歐洲地區預計將佔據最大佔有率。強大的醫療保健系統、先進的創新和強大的患者基礎定義了歐洲醫藥市場。該地區的醫藥市場佔有率深受德國、法國和英國等歐盟國家的影響。此外，歐洲因其大型製藥公司、強大的法規環境和不斷進步的醫學研究而在製藥界享有盛譽。

複合年成長率最高的地區：

亞太地區的複合年成長率最高。由於醫療基礎設施的成長、可支配收入的增加、藥物研發活動的擴大以及高齡化和人口成長等因素，亞太地區的製藥業正在迅速擴張。此外，中國和印度等新興經濟體專注於藥品製造、創新和醫療保健，對此成長至關重要。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

• 公司簡介
  • 其他市場公司的綜合分析（最多 3 家公司）
  • 主要企業SWOT分析（最多3家企業）
• 區域分割
  • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
• 競爭基準化分析
  • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

• 概述
• 相關利益者
• 調查範圍
• 調查方法
  • 資料探勘
  • 資料分析
  • 資料檢驗
  • 研究途徑
• 調查來源
  • 主要調查來源
  • 二次調查來源
  • 先決條件

第3章市場趨勢分析

• 促進因素
• 抑制因素
• 機會
• 威脅
• 新興市場
• 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

• 供應商的議價能力
• 買方議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭公司之間的敵對關係

第5章全球曲馬多藥品市場：依類型

• 口服型
• 注射式
• 其他類型

第6章全球曲馬多藥品市場：按劑型

• 藥片
• 膠囊
• 液體
• 其他劑型

第7章全球曲馬多藥品市場：按配銷通路

• 醫院藥房
• 零售藥房
• 網路藥房
• 其他配銷通路

第8章全球曲馬多藥品市場：按地區

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地區
• 中東/非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東/非洲

第9章 主要進展

• 合約、夥伴關係、協作和合資企業
• 收購和合併
• 新產品發布
• 業務擴展
• 其他關鍵策略

第10章 公司簡介

• CSL Limited
• Hexal AG
• Labopharm
• Amneal Pharmaceuticals
• Mankind Pharma Ltd
• Par Pharmaceuticals
• Grunenthal Group
• Nippon Shinyaku Co., Ltd.
• Kosher Pharmaceuticals
• Mundipharma
• Atoz Pharmaceuticals
• Rompharm Company
• Nippon Shinyaku

According to Stratistics MRC, the Global Tramadol Drug Market is accounted for $4.90 billion in 2023 and is expected to reach $8.84 billion by 2030 growing at a CAGR of 8.8% during the forecast period. An artificial opioid analgesic used to treat pain is called tramadol. It is frequently recommended for the treatment of moderate-to-severe pain. In contrast to conventional opioids, tramadol functions by inhibiting the reuptake of serotonin and norepinephrine in addition to binding to mu-opioid receptors. Moreover, when compared to other opioids, this dual action may provide a lower risk of respiratory depression while also contributing to the drug's analgesic effects.

According to Centers for Disease Control and Prevention (CDC), in the U.S. adults, about 58.5 million people had doctor-diagnosed arthritis and by 2040, an estimated 78.4 million adults will have doctor-diagnosed arthritis.

Market Dynamics:

Driver:

Increasing knowledge about pain management

The general public and healthcare professionals are becoming more aware of pain management, and this has led to a growing focus on safe and efficient pain relief methods. With its well-established history of success in the treatment of pain, tramadol gains from this development. Additionally, the ongoing need for customized treatment regimens and growing awareness of various alternatives for managing pain are factors driving tramadol's sales in the pharmaceutical industry.

Restraint:

Development of tolerance and adverse effects

One obstacle to Tramadol's widespread use is the occurrence of side effects, which include nausea, dizziness, and constipation. Furthermore, repeated use may cause tolerance, which calls for dose changes to maintain effectiveness. Healthcare practitioners must carefully weigh the need for pain relief against the control of side effects and tolerance. This decision will affect the general acceptability and long-term use of tramadol.

Opportunity:

Innovative approaches to medicine formulation

There are opportunities in the ongoing development of tramadol formulations. The effectiveness of the medication and patient compliance can be improved by research and development initiatives that concentrate on cutting-edge delivery methods, such as combination therapies or extended-release formulations. Moreover, tramadol may be positioned as a more sophisticated and adaptable pain management solution with improved formulations that address problems like dose frequency, adverse effects, and overall therapeutic outcomes.

Threat:

Alternative pain management therapies competition

The market for pain management is always changing, and new treatments are being developed as a result of continuous research. Tramadol's market share is at risk from competition from non-opioid analgesics, medical devices, and non-pharmacological interventions. Additionally, in terms of effectiveness, safety, and patient preferences, tramadol is facing competition from other pain management options that healthcare providers are investigating.

COVID-19 Impact:

The Tramadol medication market has experienced a variety of effects from the COVID-19 pandemic. The demand for pain management solutions has increased due to the increased focus on healthcare and pharmaceuticals; however, market dynamics have also been affected by disruptions in the global supply chain, changes in healthcare priorities, and the redirection of resources towards pandemic-related issues. Furthermore, lockdowns and limitations on healthcare services have also impacted patient access to care, which may have an impact on the general amount of tramadol consumed as well as prescribing practices.

The Tablet segment is expected to be the largest during the forecast period

In the tramadol drug market, the tablet segment is expected to account for the largest share. Because of their stability, portability, and simplicity of use, tablets are preferred. The extended shelf life, accurate dosage delivery, and patient-friendly qualities of these medications make them highly recommended. In many therapeutic classes, tablets provide a convenient and preferred form that is highly conducive to patient adherence to medication. Moreover, the pharmaceutical industry's largest market share is attained by tablets because of their consistent manufacturing processes, solid and portable nature, and popularity among patients and healthcare providers.

The Online Pharmacy segment is expected to have the highest CAGR during the forecast period

Within the Tramadol drug market, the online pharmacy segment is growing at the fastest rate. The swift expansion of online pharmacies can be attributed to the growing utilization of digital platforms, advancements in electronic commerce, and the ease of use they provide to customers. Additionally, people can order and obtain medications online from the convenience of their homes, saving them the trouble of physically visiting brick-and-mortar pharmacies.

Region with largest share:

European region is projected to hold the largest share. The robust healthcare system, elevated innovation, and substantial patient base define the European pharmaceutical market. The pharmaceutical market share of the area is largely influenced by European Union nations like Germany, France, and the United Kingdom. Moreover, Europe is well-known in the world of pharmaceuticals because of its large pharmaceutical companies, strong regulatory environments, and continuous medical research advancements.

Region with highest CAGR:

Asia-Pacific region is growing at the highest CAGR. Due to factors like growing healthcare infrastructure, rising disposable incomes, expanding pharmaceutical research and development activities, and an aging and sizable population, the pharmaceutical industry in Asia-Pacific is expanding rapidly. Furthermore, with an emphasis on pharmaceutical manufacturing, innovation, and healthcare accessibility, emerging economies like China and India are essential to this growth.

Key players in the market:

Some of the key players in Tramadol Drug market include CSL Limited, Hexal AG, Labopharm, Amneal Pharmaceuticals, Mankind Pharma Ltd, Par Pharmaceuticals, Grunenthal Group, Nippon Shinyaku Co., Ltd., Kosher Pharmaceuticals, Mundipharma, Atoz Pharmaceuticals, Rompharm Company and Nippon Shinyaku.

Key Developments:

In December 2023, Amneal Pharmaceuticals, Inc. and BIAL - Portela & Ca., S.A., today announced a licensing agreement where Amneal will have exclusive rights to market and distribute ONGENTYS® in the U.S. starting on December 18, 2023. Amneal expects to begin distribution of ONGENTYS® in early 2024.

In August 2023, Grunenthal GmbH and Kyowa Kirin Co have announced the successful completion of a deal to enter into a joint venture collaboration for Kyowa Kirin International's established medicines portfolio.The portfolio comprises 13 brands across six therapeutic areas primarily focused on pain management, including Abstral and PecFent for breakthrough cancer pain, Moventig for opioid-induced constipation, and Adcal-D3 for osteoporosis.

In November 2022, CSL Limited has entered into a collaboration and license agreement with Arcturus Therapeutics Holdings to access its late stage, next-generation self-amplifying mRNA (sa-mRNA) vaccine tech: prepared to spend more than $4bn on the deal to accelerate its mRNA journey.

Types Covered:

• Oral Type
• Injection Type
• Other Types

Dosage Forms Covered:

• Tablet
• Capsule
• Liquid
• Other Dosage Forms

Distribution Channels Covered:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Distribution Channels

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Emerging Markets
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Tramadol Drug Market, By Type

• 5.1 Introduction
• 5.2 Oral Type
• 5.3 Injection Type
• 5.4 Other Types

6 Global Tramadol Drug Market, By Dosage Form

• 6.1 Introduction
• 6.2 Tablet
• 6.3 Capsule
• 6.4 Liquid
• 6.5 Other Dosage Forms

7 Global Tramadol Drug Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Hospital Pharmacy
• 7.3 Retail Pharmacy
• 7.4 Online Pharmacy
• 7.5 Other Distribution Channels

8 Global Tramadol Drug Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 CSL Limited
• 10.2 Hexal AG
• 10.3 Labopharm
• 10.4 Amneal Pharmaceuticals
• 10.5 Mankind Pharma Ltd
• 10.6 Par Pharmaceuticals
• 10.7 Grunenthal Group
• 10.8 Nippon Shinyaku Co., Ltd.
• 10.9 Kosher Pharmaceuticals
• 10.10 Mundipharma
• 10.11 Atoz Pharmaceuticals
• 10.12 Rompharm Company
• 10.13 Nippon Shinyaku

List of Tables

• Table 1 Global Tramadol Drug Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Tramadol Drug Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Tramadol Drug Market Outlook, By Oral Type (2021-2030) ($MN)
• Table 4 Global Tramadol Drug Market Outlook, By Injection Type (2021-2030) ($MN)
• Table 5 Global Tramadol Drug Market Outlook, By Other Types (2021-2030) ($MN)
• Table 6 Global Tramadol Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
• Table 7 Global Tramadol Drug Market Outlook, By Tablet (2021-2030) ($MN)
• Table 8 Global Tramadol Drug Market Outlook, By Capsule (2021-2030) ($MN)
• Table 9 Global Tramadol Drug Market Outlook, By Liquid (2021-2030) ($MN)
• Table 10 Global Tramadol Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
• Table 11 Global Tramadol Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 12 Global Tramadol Drug Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 13 Global Tramadol Drug Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 14 Global Tramadol Drug Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 15 Global Tramadol Drug Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
• Table 16 North America Tramadol Drug Market Outlook, By Country (2021-2030) ($MN)
• Table 17 North America Tramadol Drug Market Outlook, By Type (2021-2030) ($MN)
• Table 18 North America Tramadol Drug Market Outlook, By Oral Type (2021-2030) ($MN)
• Table 19 North America Tramadol Drug Market Outlook, By Injection Type (2021-2030) ($MN)
• Table 20 North America Tramadol Drug Market Outlook, By Other Types (2021-2030) ($MN)
• Table 21 North America Tramadol Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
• Table 22 North America Tramadol Drug Market Outlook, By Tablet (2021-2030) ($MN)
• Table 23 North America Tramadol Drug Market Outlook, By Capsule (2021-2030) ($MN)
• Table 24 North America Tramadol Drug Market Outlook, By Liquid (2021-2030) ($MN)
• Table 25 North America Tramadol Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
• Table 26 North America Tramadol Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 27 North America Tramadol Drug Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 28 North America Tramadol Drug Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 29 North America Tramadol Drug Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 30 North America Tramadol Drug Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
• Table 31 Europe Tramadol Drug Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Europe Tramadol Drug Market Outlook, By Type (2021-2030) ($MN)
• Table 33 Europe Tramadol Drug Market Outlook, By Oral Type (2021-2030) ($MN)
• Table 34 Europe Tramadol Drug Market Outlook, By Injection Type (2021-2030) ($MN)
• Table 35 Europe Tramadol Drug Market Outlook, By Other Types (2021-2030) ($MN)
• Table 36 Europe Tramadol Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
• Table 37 Europe Tramadol Drug Market Outlook, By Tablet (2021-2030) ($MN)
• Table 38 Europe Tramadol Drug Market Outlook, By Capsule (2021-2030) ($MN)
• Table 39 Europe Tramadol Drug Market Outlook, By Liquid (2021-2030) ($MN)
• Table 40 Europe Tramadol Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
• Table 41 Europe Tramadol Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 42 Europe Tramadol Drug Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 43 Europe Tramadol Drug Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 44 Europe Tramadol Drug Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 45 Europe Tramadol Drug Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
• Table 46 Asia Pacific Tramadol Drug Market Outlook, By Country (2021-2030) ($MN)
• Table 47 Asia Pacific Tramadol Drug Market Outlook, By Type (2021-2030) ($MN)
• Table 48 Asia Pacific Tramadol Drug Market Outlook, By Oral Type (2021-2030) ($MN)
• Table 49 Asia Pacific Tramadol Drug Market Outlook, By Injection Type (2021-2030) ($MN)
• Table 50 Asia Pacific Tramadol Drug Market Outlook, By Other Types (2021-2030) ($MN)
• Table 51 Asia Pacific Tramadol Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
• Table 52 Asia Pacific Tramadol Drug Market Outlook, By Tablet (2021-2030) ($MN)
• Table 53 Asia Pacific Tramadol Drug Market Outlook, By Capsule (2021-2030) ($MN)
• Table 54 Asia Pacific Tramadol Drug Market Outlook, By Liquid (2021-2030) ($MN)
• Table 55 Asia Pacific Tramadol Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
• Table 56 Asia Pacific Tramadol Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 57 Asia Pacific Tramadol Drug Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 58 Asia Pacific Tramadol Drug Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 59 Asia Pacific Tramadol Drug Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 60 Asia Pacific Tramadol Drug Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
• Table 61 South America Tramadol Drug Market Outlook, By Country (2021-2030) ($MN)
• Table 62 South America Tramadol Drug Market Outlook, By Type (2021-2030) ($MN)
• Table 63 South America Tramadol Drug Market Outlook, By Oral Type (2021-2030) ($MN)
• Table 64 South America Tramadol Drug Market Outlook, By Injection Type (2021-2030) ($MN)
• Table 65 South America Tramadol Drug Market Outlook, By Other Types (2021-2030) ($MN)
• Table 66 South America Tramadol Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
• Table 67 South America Tramadol Drug Market Outlook, By Tablet (2021-2030) ($MN)
• Table 68 South America Tramadol Drug Market Outlook, By Capsule (2021-2030) ($MN)
• Table 69 South America Tramadol Drug Market Outlook, By Liquid (2021-2030) ($MN)
• Table 70 South America Tramadol Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
• Table 71 South America Tramadol Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 72 South America Tramadol Drug Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 73 South America Tramadol Drug Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 74 South America Tramadol Drug Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 75 South America Tramadol Drug Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
• Table 76 Middle East & Africa Tramadol Drug Market Outlook, By Country (2021-2030) ($MN)
• Table 77 Middle East & Africa Tramadol Drug Market Outlook, By Type (2021-2030) ($MN)
• Table 78 Middle East & Africa Tramadol Drug Market Outlook, By Oral Type (2021-2030) ($MN)
• Table 79 Middle East & Africa Tramadol Drug Market Outlook, By Injection Type (2021-2030) ($MN)
• Table 80 Middle East & Africa Tramadol Drug Market Outlook, By Other Types (2021-2030) ($MN)
• Table 81 Middle East & Africa Tramadol Drug Market Outlook, By Dosage Form (2021-2030) ($MN)
• Table 82 Middle East & Africa Tramadol Drug Market Outlook, By Tablet (2021-2030) ($MN)
• Table 83 Middle East & Africa Tramadol Drug Market Outlook, By Capsule (2021-2030) ($MN)
• Table 84 Middle East & Africa Tramadol Drug Market Outlook, By Liquid (2021-2030) ($MN)
• Table 85 Middle East & Africa Tramadol Drug Market Outlook, By Other Dosage Forms (2021-2030) ($MN)
• Table 86 Middle East & Africa Tramadol Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 87 Middle East & Africa Tramadol Drug Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 88 Middle East & Africa Tramadol Drug Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 89 Middle East & Africa Tramadol Drug Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 90 Middle East & Africa Tramadol Drug Market Outlook, By Other Distribution Channels (2021-2030) ($MN)